Literature DB >> 13670627

[Semiquantitative determination of physical dependence in morphine and methadon therapy].

O SCHRAPPE, J M BURCHARD, K GEHLKEN.   

Abstract

Entities:  

Keywords:  DEPRESSION; METHADON; MORPHINE/addiction

Mesh：

Substances：

Year:  1959        PMID： 13670627     DOI： 10.1007/bf00361098

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr


× No keyword cloud information.
  6 in total

1.  [Physical dependence following prolonged administration of N-allylnormorphine].

Authors:  O SCHRAPPE
Journal:  Arzneimittelforschung       Date:  1959-02

2.  [Pharmacopsychiatric studies on the mechanism of action of opium alkaloids in endogenous psychoses].

Authors:  J M BURCHARD
Journal:  Nervenarzt       Date:  1958-03-20       Impact factor: 1.214

3.  Synthetic substances with morphine-like effect; relationship between analgesic action and addiction liability, with a discussion of the chemical structure of addiction-producing substances.

Authors:  N B EDDY; H HALBACH; O J BRAENDEN
Journal:  Bull World Health Organ       Date:  1956       Impact factor: 9.408

4.  [Pharmacological diagnosis of alkaloid addiction with the help of some opiate antagonists].

Authors:  S WENDE; O SCHRAPPE
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1956

5.  N-Allylnormorphine: effects of single doses and precipitation of acute abstinence syndromes during addiction to morphine; methadone or heroin in man (post addicts).

Authors:  A WIKLER; H F FRASER; H ISBELL
Journal:  J Pharmacol Exp Ther       Date:  1953-09       Impact factor: 4.030

6.  The addiction liability of methadon (amidone, dolophine, 10820) and its use in the treatment of the morphine abstinence syndrome.

Authors:  H ISBELL; V H VOGEL
Journal:  Am J Psychiatry       Date:  1949-06       Impact factor: 18.112
  6 in total
  1 in total

1.  Tests for addiction (chronic intoxication) of morphine type.

Authors:  H HALBACH; N B EDDY
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.